Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
Journal: The Journal of antimicrobial chemotherapy
Published: April 19, 2016
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection - Authors' reply.
Journal: Lancet (London, England)
Published: October 14, 2015
Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial.
Journal: The Journal of antimicrobial chemotherapy
Published: August 26, 2015
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
Journal: Lancet (London, England)
Published: May 02, 2015
Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects.
Journal: The Journal of antimicrobial chemotherapy
Published: July 10, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026